Skip to main content
Clinical Trials/CTRI/2025/07/090726
CTRI/2025/07/090726Not yet recruitingPhase 2/3

Randomized controlled clinical trial to evaluate the efficacy of Nimba Kshara Pratisaran in the management of Post Operative Partial Fistulectomy Hypergranulated Wound

CSMSS Ayurved Mahavidyalaya and Rugnalaya, Kanchanwadi, Aurangabad1 site in 1 country92 target enrollmentStarted: July 11, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
92
Locations
1
Primary Endpoint
To reduce signs and symptoms of hypergranulation i.e. Pain, Itching, Size of Wound, Margin, Height of granulation tissue till 28 days

Study Overview

Brief Summary

Hypergranulation is excessive granulation that rises above the wound surface. In post operative partial fistulectomy procedure, Hypergranulation is seen near the external opening of fistula.

Pratisarneeya kshara is used in the wound with symptoms like indurations, itching, and have raised hypertrophied granulation tissue.

Nimba kshara pratisaran is having Tridosh nashana, chedana, bhedana, lekhana and ropana properties which is useful for wound healing.

A Study will be conducted on 92 diagnosed patients having classical signs and  symptoms of Hypergranulation in post operative partial fistulectomy wound.

Written informed consent will be taken.

Inital assessment on 1st day, then randomization will be done.

Group allocation with Group A and

Follow up on 7th, 14th, 21st, 28th day.

Observations and result will be noted.

Statistical analysis

Discussion and conclusion

Summary.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Clinically diagnosed Patients having classical signs of hypergranulation in post operative partial fistulectomy wound , selection will be irrespective of sex, religion, and socioeconomic status, Age between 16-70 years.
  • Wound size upto length of 4cm into 1 cm.

Exclusion Criteria

  • Patients with malignant ulcers.
  • Patients below age 16 and above 70 years.
  • Gangrenous wond.
  • Bleeding disorders.
  • Patients suffering from DM, HTN.

Outcomes

Primary Outcomes

To reduce signs and symptoms of hypergranulation i.e. Pain, Itching, Size of Wound, Margin, Height of granulation tissue till 28 days

Time Frame: Baseline, 7th day, 14th day, 21st day, 28th day

Secondary Outcomes

  • To reduce the size of wound.(Baseline, 7th day, 14th day, 21st day, 28th day)

Investigators

Sponsor
CSMSS Ayurved Mahavidyalaya and Rugnalaya, Kanchanwadi, Aurangabad
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Snehal Shivaji Kayande

CSMSS Ayurved Mahavidyalaya and Rugnalaya

Study Sites (1)

Loading locations...

Similar Trials